The behavior engine driving the future of interactive digital entertainment.

Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as Type 1 Diabetes as well as genetic and acquired liver diseases.

Cent ML is a pioneering machine learning startup focused on enhancing compute efficiency for AI applications. Their platform offers solutions for training, fine-tuning, and serving AI models, significantly reducing costs and deployment times. Key products include CServe, which provides up to 8x faster model serving and 70% lower costs, and open-source tools like Hidet and Deep View for optimizing deep learning processes. With a strong foundation from experts in AI and ML, Cent ML aims to make advanced AI technologies accessible and efficient, positioning itself as a leader in the optimization of machine learning systems.

Chemix is revolutionizing the EV battery industry with its AI-powered platform, MIX, which accelerates battery design by 5-10x. The company specializes in high-performance batteries tailored for various EV segments, including e-motorcycles and sports cars, utilizing a vast dataset to optimize designs. Chemix's batteries are currently in production, offering up to 30% better performance than existing technologies while focusing on sustainable chemistries that minimize or eliminate cobalt and nickel. With strategic investments from notable firms, Chemix is well-positioned in the rapidly evolving battery market.

Climate Ai is a pioneering enterprise climate resilience platform that utilizes artificial intelligence to help businesses across the food and agriculture value chain mitigate climate risks and seize new opportunities. With patented models and hyper-local climate insights, Climate Ai enables companies to make informed decisions, adapt operations, and enhance supply chain reliability. The platform has been adopted in over 50 countries, climate-proofing more than 1000 locations, and is recognized for its innovative approach to climate adaptation, making it a leader in the industry.

Cohere is a leading AI platform that empowers enterprises with high-performance, scalable language models and advanced retrieval systems. Their innovative products, including Command, Embed, and Rerank, are designed to streamline workflows and enhance AI capabilities across various industries such as financial services, healthcare, and manufacturing. With a focus on security and customization, Cohere provides private deployment options and fine-tuning capabilities, making it a preferred choice for organizations looking to leverage AI for real-world applications. The company is positioned at the forefront of AI technology, driven by a commitment to research and collaboration, and is trusted by industry leaders worldwide.

Crossing Minds is a cutting-edge AI platform that specializes in personalized information retrieval and recommendations for enterprises. Leveraging advanced embeddings, large-scale training, and proprietary RAG technologies, the platform delivers real-time, scalable performance tailored to complex databases and unique use cases. With a focus on enhancing customer engagement through personalized recommendations, Crossing Minds has demonstrated significant traction in various industries, including e-commerce and financial institutions, by driving substantial increases in sales and conversion rates. Their technology is designed for enterprises that require customized solutions, ensuring accurate data processing and enriched insights for improved decision-making.

DatologyAI is an AI-data curation startup that specializes in automated data curation for generative AI. Their product optimizes training efficiency, maximizes performance, and reduces compute costs by providing fully automated data curation that integrates seamlessly into existing infrastructures. The solution is modality-agnostic, capable of handling various data types without requiring labels, and is designed to scale with datasets of petabytes or more. With a world-class team and backing from prominent venture funds, DatologyAI positions itself as a leader in the AI data curation market, catering to businesses looking to enhance their AI capabilities securely and efficiently.

Delphina is an innovative AI Data Scientist platform that automates data science processes to enhance predictive analytics. It offers tools for dynamic pricing, sales forecasting, and personalization, enabling teams to build sophisticated machine learning models that improve performance by double-digit percentages. By integrating seamlessly with existing MLOps stacks, Delphina empowers organizations to deploy predictive pipelines efficiently, positioning itself as a leader in the AI-driven data science market.

Firsthand is transforming how advertisers and publishers attract, inspire, and engage consumers through AI-powered Brand Agents. The platform combines Lakebed™, an AI-first data rights management solution, with custom-built Brand Agents that deliver dynamic, personalized experiences to consumers in real-time. This innovative approach allows brands to maintain control over their data and customer interactions while gaining valuable insights into consumer behavior. Founded by pioneers in digital advertising, Firsthand aims to empower companies to thrive in the AI era by fostering direct connections with consumers without intermediaries.

Genesis Therapeutics is leveraging an advanced molecular AI platform, GEMS, to discover and develop highly potent and selective drugs for challenging protein targets. The company focuses on using AI and physics research to synthesize drug candidates with unprecedented speed and efficacy, positioning itself as a leader in the biotech industry. With a strong emphasis on collaboration among interdisciplinary teams, Genesis aims to revolutionize drug discovery and improve patient outcomes. Their recent strategic collaborations and significant funding rounds highlight their traction and market position in the competitive landscape of drug development.

Graft's intelligence layer is the bridge between company information and business value. Now your teams can quickly access the collective intelligence of your organization - just connect your data, enrich it with expertise, and Graft delivers instant, relevant answers through a simple chat interface.